| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/12/2008 | CN101139314A Method for preparing (3R,4R)-3,4-dihydroxy pyrrolidine-2-ketone |
| 03/12/2008 | CN101139304A Conjugated dienamides and uses thereof |
| 03/12/2008 | CN100374441C 2-substituted benzyl-5,7-dihydrocarbyl-3,7-dihydro pyrroline [2,3-d] pyromidine-4-one derivative ,its preparation and medicinal use |
| 03/12/2008 | CN100374438C Pre-organized tricyclic integrase inhibitor compounds |
| 03/12/2008 | CN100374419C Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides |
| 03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
| 03/11/2008 | US7342120 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 03/11/2008 | US7342041 viricide; synergistic mixture with antiviral agent (ribavirin) and alpha - or pegylated interferon; Human Immunogeficiency Virus, Acquired Immune Deficiency Syndrome |
| 03/11/2008 | US7342005 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; favourable duration of action; infections |
| 03/11/2008 | CA2559374A1 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 03/06/2008 | WO2008026678A1 Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation |
| 03/06/2008 | WO2008026527A1 Method for producing 3-cyanopyrrolidine derivative or salt thereof |
| 03/06/2008 | WO2007000641A8 Prostaglandin derivatives |
| 03/06/2008 | US20080058528 Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 03/06/2008 | US20080058516 Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing alpha-keto amide compound using them |
| 03/06/2008 | US20080058389 Carboxamides |
| 03/06/2008 | US20080058382 Polyamine compounds |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | US20080058304 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 03/06/2008 | CA2661776A1 Solid citrate and tartrate salts of dpp-iv inhibitors |
| 03/05/2008 | EP1893574A2 Peptide deformylase (pdf) inhibitors 4 |
| 03/05/2008 | EP1893573A1 Inhibitors of hcv replication |
| 03/05/2008 | EP1893572A2 Factor xa inhibitors |
| 03/05/2008 | EP1893569A1 Sulfonamide compounds and uses thereof |
| 03/05/2008 | EP1893200A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/05/2008 | EP1560811B9 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/05/2008 | CN101137623A N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 03/05/2008 | CN101137622A Substituted gamma lactams as therapeutic agents |
| 03/05/2008 | CN101137616A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 03/05/2008 | CN101137372A Mitotic kinesin inhibitors |
| 03/05/2008 | CN101134740A Method for synthesizing ketorolac ammonia butanetriol key intermediate compound benzoyl pyrrole |
| 03/05/2008 | CN100372840C Intermediate for the preparation of epimino |
| 03/05/2008 | CN100372831C Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 03/04/2008 | US7339045 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, lipids, cells, virus particles, fatty acids, polysaccharides) |
| 03/04/2008 | US7338976 Administering heterocyclic esters and amides: 3-phenyl-1-propyl(2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-(4-thiazolidine)carboxylate; 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; immunosuppressants; affinity for an FK binding protein-type immunophilin |
| 03/04/2008 | US7338975 Lactams as modulators of chemokine receptor activity |
| 03/04/2008 | US7338952 N-[2-[4-[(4-chlorophenyl)ethynyl]-2-methylphenoxy]-1-methylethyl]-1,4-benzenedimethanamine; phosphorylation, polymorphonuclear leukocyte, macrophage, lipopolysaccharide, tumor necrosis factor- alpha, cytokine IFN- gamma, interleukin-2 mediated disorders ; arthritis, osteoarthritis, Alzheimer's disease |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 03/04/2008 | CA2329210C Process for preparation of enantiomerically pure n-methyl-n-[(1s)-1-phenyl-2((3s)-3-hydroxypyrrolidin-1-yl) ethyl]-2,2-diphenylacetamide |
| 02/28/2008 | WO2008024302A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008022961A1 N-heterocycles supported on polymers through triazole or tetrazole linkers for organocatalytic applications |
| 02/28/2008 | WO2008022945A1 Aryl sulfonamides with an analgesic action |
| 02/28/2008 | WO2007016136A3 Organic nitric oxide enhancing salts of cyclooxygenase-2 selective inhibitors, compositons and methods of use |
| 02/28/2008 | US20080051449 Preparation of atorvastatin calcium form vi and compositions thereof |
| 02/28/2008 | US20080051446 Heterocyclocarboxamide Derivatives |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051433 Pyrrole-3-Carboxamide Derivatives for the Treatment of Obesity |
| 02/28/2008 | US20080051416 Novel Compounds |
| 02/28/2008 | US20080050657 Quaternary Ammonium Salt, Electrolyte, Electrolyte, Solution and Electrochemical Device |
| 02/28/2008 | CA2675942A1 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 02/28/2008 | CA2663598A1 New compounds |
| 02/28/2008 | CA2661440A1 Compounds for treating proliferative disorders |
| 02/28/2008 | CA2660524A1 Compounds for treating proliferative disorders |
| 02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
| 02/27/2008 | EP1892238A1 1, 2-di(cyclic group)substituted benzene derivative |
| 02/27/2008 | EP1892042A1 Proline derivatives supported on polymers through triazole or tetrazole linkers for organocatalytic applications |
| 02/27/2008 | EP1891038A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators |
| 02/27/2008 | EP1802307B1 Pyrrolidine derivatives as histamine receptors ligands |
| 02/27/2008 | EP1425268B1 Organic sulfates as ionic liquids |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/27/2008 | CN101133042A Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 02/27/2008 | CN101133023A Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof |
| 02/27/2008 | CN101133022A Substituted 2-pyrrolidone derivatives as fungicides and insecticides |
| 02/27/2008 | CN101133021A Crystallisation and purification of glycopyrronium bromide |
| 02/27/2008 | CN101130514A Intermediate for the preparation of epimino |
| 02/27/2008 | CN100371324C Dialkyl and diaryl tetrasubstituted heterocyclic compounds, preparing process and use thereof |
| 02/27/2008 | CN100371323C Cyanopyrrolidine derivatives |
| 02/27/2008 | CN100371322C 2-pyrrolidone derivatives as prostanoid agonists |
| 02/27/2008 | CN100370983C Medicinal composition |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/26/2008 | US7335781 perform as superior catalysts in asymmetric addition reactions wherein organic zinc and aldehyde are involved; Such catalyses are economically useful for industries |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335680 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335632 Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secretase activity; Alzheimer's disease |
| 02/26/2008 | CA2322195C Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 02/21/2008 | WO2008021956A2 Acylaminoheteroaryl hepatitis c virus protease inhibitors |
| 02/21/2008 | WO2008021796A2 Pyrrolidinone anilines as progesterone receptor modulators |
| 02/21/2008 | WO2008021029A2 Process for making lactam tachykinin receptor antagonists |
| 02/21/2008 | WO2008020617A1 Process for production of brominated acetophenone |
| 02/21/2008 | WO2007010222A3 Therapeutic agents |
| 02/21/2008 | US20080045542 anticarcinogenic agent, 3-{4-[3-(2-Fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-2-carboxamide, for treating cancer; modulating Protein kinases, relieve the side effect of chemotherapy |
| 02/21/2008 | US20080045530 Organic Compounds and Their Uses |
| 02/21/2008 | US20080045509 Substituted benzyl amine compounds |
| 02/21/2008 | US20080045504 Benzonitrile Derivatives to Treat Musculoskeletal Frailty |
| 02/21/2008 | US20080045497 Substituted aniline derivatives |
| 02/21/2008 | US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide |
| 02/21/2008 | US20080045470 Ceramides and Apoptosis-Signaling Ligand |
| 02/21/2008 | CA2660911A1 Thiourea compounds |
| 02/21/2008 | CA2660397A1 Pyrrolidinone anilines as progesterone receptor modulators |
| 02/21/2008 | CA2660272A1 Process for making lactam tachykinin receptor antagonists |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889842A1 Heterocyclic compound |
| 02/20/2008 | EP1889834A1 Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same |